{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:36:14Z","timestamp":1776216974387,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00417-022-05730-6","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T02:02:18Z","timestamp":1655863338000},"page":"3809-3816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study"],"prefix":"10.1007","volume":"260","author":[{"given":"Yu-Bai","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Guor","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Sue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"5730_CR1","unstructured":"World Health Organization. (2020) VISION-2020, No. SEA-Blindness-1, WHO Report of the Expert Group Meeting for South-East Asia."},{"issue":"2","key":"5730_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17469899.2019.1596026","volume":"14","author":"ED Hansen","year":"2019","unstructured":"Hansen ED, Hartnett ME (2019) A review of treatment for retinopathy of prematurity. Expert review of ophthalmology 14(2):73\u201387","journal-title":"Expert review of ophthalmology"},{"key":"5730_CR3","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","unstructured":"Early Treatment for Retinopathy of Prematurity Cooperative Group (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121:1684\u20131696","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"5730_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1120672118770557","volume":"29","author":"J Liang","year":"2019","unstructured":"Liang J (2019) Systematic review and meta-analysis of the negative outcomes of retinopathy of prematurity treated with laser photocoagulation. Eur J Ophthalmol 29(2):223\u2013228","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"5730_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.21037\/tp.2020.03.01","volume":"9","author":"Y Wang","year":"2020","unstructured":"Wang Y, Pi LH, Zhao RL et al (2020) Refractive status and optical components of premature babies with or without retinopathy of prematurity at 7 years old. Translational Pediatrics 9(2):108","journal-title":"Translational Pediatrics"},{"issue":"8","key":"5730_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bjophthalmol-2017-311345","volume":"102","author":"BA Darlow","year":"2018","unstructured":"Darlow BA, Elder MJ, Kimber B et al (2018) Vision in former very low birthweight young adults with and without retinopathy of prematurity compared with term born controls: the NZ 1986 VLBW follow-up study. Br J Ophthalmol 102(8):1041\u20131046","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"5730_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ophtha.2007.07.028","volume":"115","author":"GE Quinn","year":"2008","unstructured":"Quinn GE, Dobson V, Davitt BV et al (2008) Early Treatment for Retinopathy of Prematurity Cooperative Group: progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology 115(6):1058\u20131064","journal-title":"Ophthalmology"},{"issue":"9","key":"5730_CR8","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1167\/iovs.13-11765","volume":"54","author":"J Wang","year":"2013","unstructured":"Wang J, Ren X, Shen L et al (2013) Development of refractive error in individual children with regressed retinopathy of prematurity. Invest Ophthalmol Vis Sci 54(9):6018\u20136024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5730_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/EB.S95021","volume":"8","author":"A Moskowitz","year":"2016","unstructured":"Moskowitz A, Hansen RM, Fulton AB (2016) Retinal, visual, and refractive development in retinopathy of prematurity. Eye and brain 8:103","journal-title":"Eye and brain"},{"issue":"4","key":"5730_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000439182","volume":"234","author":"HK Kuo","year":"2015","unstructured":"Kuo HK, Sun IT, Chung MY et al (2015) Refractive error in patients with retinopathy of prematurity after laser photocoagulation or bevacizumab monotherapy. Ophthalmologica 234(4):211\u2013217","journal-title":"Ophthalmologica"},{"issue":"12","key":"5730_CR11","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1167\/iovs.10-5234","volume":"51","author":"TC Chen","year":"2010","unstructured":"Chen TC, Tsai TH, Shih YF et al (2010) Long-term evaluation of refractive status and optical components in eyes of children born prematurely. Invest Ophthalmol Vis Sci 51(12):6140\u20136148","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4 Suppl","key":"5730_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/OPX.0000000000000533","volume":"92","author":"L Ruan","year":"2015","unstructured":"Ruan L, Shan HD, Liu XZ et al (2015) Refractive status of Chinese with laser-treated retinopathy of prematurity. Optom Vis Sci 92(4 Suppl):S3","journal-title":"Optom Vis Sci"},{"issue":"5","key":"5730_CR13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.18240\/ijo.2020.05.17","volume":"13","author":"SD Wang","year":"2020","unstructured":"Wang SD, Zhang GM (2020) Laser therapy versus intravitreal injection of anti-VEGF agents in monotherapy of ROP: a meta-analysis. Int J Ophthalmol 13(5):806","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"5730_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225643","volume":"14","author":"QQ Tan","year":"2019","unstructured":"Tan QQ, Christiansen SP, Wang J (2019) Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: a meta-analysis and systematic review. PLoS ONE 14(12):e0225643","journal-title":"PLoS ONE"},{"issue":"5","key":"5730_CR15","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","volume":"122","author":"CK Hwang","year":"2015","unstructured":"Hwang CK, Hubbard GB, Hutchinson AK et al (2015) Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122(5):1008\u20131015","journal-title":"Ophthalmology"},{"issue":"11","key":"5730_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA ophthalmology 132(11):1327\u20131333","journal-title":"JAMA ophthalmology"},{"issue":"4","key":"5730_CR17","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41433-019-0605-x","volume":"34","author":"T Young-Zvandasara","year":"2020","unstructured":"Young-Zvandasara T, Popiela M, Preston H et al (2020) Is the severity of refractive error dependent on the quantity and extent of retinal laser ablation for retinopathy of prematurity. Eye 34(4):740\u2013745","journal-title":"Eye"},{"issue":"2","key":"5730_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jaapos.2018.10.013","volume":"23","author":"N Anand","year":"2019","unstructured":"Anand N, Blair MP, Greenwald MJ et al (2019) Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. Journal of American Association for Pediatric Ophthalmology and Strabismus 23(2):88\u2013101","journal-title":"Journal of American Association for Pediatric Ophthalmology and Strabismus"},{"issue":"6","key":"5730_CR19","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.ajo.2008.01.026","volume":"145","author":"PS Baker","year":"2008","unstructured":"Baker PS, Tasman W (2008) Myopia in adults with retinopathy of prematurity. Am J Ophthalmol 145(6):1090\u20131094","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"5730_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/eye.2012.263","volume":"27","author":"CS Yang","year":"2013","unstructured":"Yang CS, Wang AG, Shih YF et al (2013) Astigmatism and biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age. Eye 27(3):374\u2013381","journal-title":"Eye"},{"issue":"8","key":"5730_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","volume":"102","author":"An international classification of retinopathy of prematurity","year":"1984","unstructured":"An international classification of retinopathy of prematurity (1984) The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 102(8):1130\u20131134","journal-title":"Arch Ophthalmol"},{"key":"5730_CR22","doi-asserted-by":"crossref","unstructured":"Palmer EA. (1990) Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP). Doc Ophthalmol 74(3): p. 245\u201351.","DOI":"10.1007\/BF02482615"},{"issue":"2","key":"5730_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/09273972.2016.1159232","volume":"24","author":"M Gunay","year":"2016","unstructured":"Gunay M, Sekeroglu MA, Bardak H et al (2016) Evaluation of refractive errors and ocular biometric outcomes after intravitreal bevacizumab for retinopathy of prematurity. Strabismus 24(2):84\u201388","journal-title":"Strabismus"},{"issue":"9","key":"5730_CR24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/eye.2014.172","volume":"28","author":"YH Chen","year":"2014","unstructured":"Chen YH, Chen SN, Lien RI, Shih CP, Chao AN, Chen KJ, Chuang CC (2014) Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. Eye 28(9):1080\u20131087","journal-title":"Eye"},{"key":"5730_CR25","doi-asserted-by":"crossref","unstructured":"McLoone EM, O\u2019Keefe M, McLoone SF, et al. (2006) Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus 0(5), 454\u2013459.","DOI":"10.1016\/j.jaapos.2006.05.005"},{"issue":"9","key":"5730_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","volume":"119","author":"WC Wu","year":"2012","unstructured":"Wu WC, Lin RI, Shih CP et al (2012) Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology 119(9):1907\u20131916","journal-title":"Ophthalmology"},{"issue":"9","key":"5730_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4103\/ijo.IJO_872_16","volume":"65","author":"S Kaur","year":"2017","unstructured":"Kaur S, Sukhija J, Katoch D et al (2017) Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity. Indian J Ophthalmol 65(9):835","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"5730_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/archopht.1985.01050060045020","volume":"103","author":"RA Gordon","year":"1985","unstructured":"Gordon RA, Donzis PB (1985) Refractive development of the human eye. Arch Ophthalmol 103(6):785\u2013789","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"5730_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/bjo.2004.045815","volume":"89","author":"J Sahni","year":"2005","unstructured":"Sahni J, Subhedar NV, Clark D (2005) Treated threshold stage 3 versus spontaneously regressed subthreshold stage 3 retinopathy of prematurity: a study of motility, refractive, and anatomical outcomes at 6 months and 36 months. Br J Ophthalmol 89(2):154\u2013159","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"5730_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3928\/01913913-20081101-02","volume":"45","author":"A Dhawan","year":"2008","unstructured":"Dhawan A, Dogra M, Vinekar A et al (2008) Structural sequelae and refractive outcome after successful laser treatment for threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 45(6):356\u2013361","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"6","key":"5730_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/IAE.0b013e318169faee","volume":"28","author":"R Axer-Siegel","year":"2008","unstructured":"Axer-Siegel R, Maharshak I, Snir M et al (2008) Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina 28(6):839\u2013846","journal-title":"Retina"},{"issue":"6","key":"5730_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.ajo.2013.01.014","volume":"155","author":"BC Harder","year":"2013","unstructured":"Harder BC, Schlichtenbrede FC, von-Baltz S, et al (2013) Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Am J Ophthalmol 155(6):1119\u20131124","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5730_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.47102\/https:\/\/doi.org\/10.47102\/annals-acadmedsg.V33N1p27","volume":"33","author":"LK Lin","year":"2004","unstructured":"Lin LK, Shih YT, Hsiao CT et al (2004) Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Annals-Academy of Medicine Singapore 33(1):27\u201333","journal-title":"Annals-Academy of Medicine Singapore"},{"issue":"6","key":"5730_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/0301-4738.86306","volume":"59","author":"D Katoch","year":"2011","unstructured":"Katoch D, Sanghi G, Dogra MR et al (2011) Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes. Indian J Ophthalmol 59(6):423","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"5730_CR35","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/0042-6989(94)00227-D","volume":"35","author":"CL Lue","year":"1995","unstructured":"Lue CL, Hansen RM, Reisner DS et al (1995) The course of myopia in children with mild retinopathy of prematurity. Vision Res 35(9):1329\u20131335","journal-title":"Vision Res"},{"issue":"12","key":"5730_CR36","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0161-6420(86)33523-1","volume":"93","author":"RA Gordon","year":"1986","unstructured":"Gordon RA, Donzis PB (1986) Myopia associated with retionopathy of prematurity. Ophthalmology 93(12):1593\u20131598","journal-title":"Ophthalmology"},{"issue":"2","key":"5730_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0161-6420(00)00527-3","volume":"108","author":"GE Quinn","year":"2001","unstructured":"Quinn GE, Dobson V, Siatkowski RM et al (2001) Does cryotherapy affect refractive error?: results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial. Ophthalmology 108(2):343\u2013347","journal-title":"Ophthalmology"},{"issue":"1","key":"5730_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3341\/kjo.1992.6.1.44","volume":"6","author":"JY Kim","year":"1992","unstructured":"Kim JY, Kwak SI, Yu YS (1992) Myopia in premature infants at the age of 6 months. Korean J Ophthalmol 6(1):44\u201349","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"5730_CR39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/bjo.80.11.998","volume":"80","author":"DM Knight-Nanan","year":"1996","unstructured":"Knight-Nanan DM, O\u2019Keefe M (1996) Refractive outcome in eyes with retinopathy of prematurity treated with cryotherapy or diode laser: 3 year follow up. Br J Ophthalmol 80(11):998\u20131001","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"5730_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaapos.2012.10.025","volume":"17","author":"GE Quinn","year":"2013","unstructured":"Quinn GE, Dobson V, Davitt BV et al (2013) Early Treatment for Retinopathy of Prematurity Cooperative Group: progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. Journal of American Association for Pediatric Ophthalmology and Strabismus 17(2):124\u2013128","journal-title":"Journal of American Association for Pediatric Ophthalmology and Strabismus"},{"issue":"9","key":"5730_CR41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ophtha.2005.03.025","volume":"112","author":"BV Davitt","year":"2005","unstructured":"Davitt BV, Dobson V, Good WV et al (2005) Early Treatment for Retinopathy of Prematurity Cooperative Group: prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology 112(9):1564\u20131568","journal-title":"Ophthalmology"},{"issue":"suppl 4","key":"5730_CR42","first-page":"S107","volume":"95","author":"S Warrasak","year":"2012","unstructured":"Warrasak S, Nawarutkulchai S, Sinsawat P (2012) Functional result and visual outcome in early versus conventional treatment of retinopathy of prematurity. J Med Assoc Thai 95(suppl 4):S107\u2013S115","journal-title":"J Med Assoc Thai"},{"issue":"5","key":"5730_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/bjophthalmol-2019-314610","volume":"104","author":"YC Chen","year":"2020","unstructured":"Chen YC, Chen SN (2020) Foveal microvasculature, refractive errors, optical biometry and their correlations in school-aged children with retinopathy of prematurity after intravitreal antivascular endothelial growth factors or laser photocoagulation. Br J Ophthalmol 104(5):691\u2013696","journal-title":"Br J Ophthalmol"},{"key":"5730_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","volume":"192","author":"YS Lee","year":"2018","unstructured":"Lee YS, See LC, Chang SH et al (2018) Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment. Am J Ophthalmol 192:20\u201330","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"5730_CR45","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/eye.2014.172","volume":"28","author":"YH Chen","year":"2014","unstructured":"Chen YH, Chen SN, Lien RI et al (2014) Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. Eye 28(9):1080\u20131087","journal-title":"Eye"},{"issue":"2","key":"5730_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaapos.2015.01.009","volume":"19","author":"M Isaac","year":"2015","unstructured":"Isaac M, Mireskandari K, Tehrani N (2015) Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser. Journal of American Association for Pediatric Ophthalmology and Strabismus 19(2):140\u2013144","journal-title":"Journal of American Association for Pediatric Ophthalmology and Strabismus"},{"issue":"2","key":"5730_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/bjo.84.2.138","volume":"84","author":"MY Choi","year":"2000","unstructured":"Choi MY, Park IK, Yu YS (2000) Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness. Br J Ophthalmol 84(2):138\u2013143","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"5730_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaapos.2004.12.018","volume":"9","author":"E Garcia-Valenzuela","year":"2005","unstructured":"Garcia-Valenzuela E, Kaufman LM (2005) High myopia associated with retinopathy of prematurity is primarily lenticular. Journal of American Association for Pediatric Ophthalmology and Strabismus 9(2):121\u2013128","journal-title":"Journal of American Association for Pediatric Ophthalmology and Strabismus"},{"issue":"1","key":"5730_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/eye.2000.6","volume":"14","author":"D Kent","year":"2000","unstructured":"Kent D, Pennie F, Laws D et al (2000) The influence of retinopathy of prematurity on ocular growth. Eye 14(1):23\u201329","journal-title":"Eye"},{"issue":"1","key":"5730_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-015-0099-7","volume":"15","author":"SC Wu","year":"2015","unstructured":"Wu SC, Lee YS, Wu WC et al (2015) Acute angle-closure glaucoma in retinopathy of prematurity following pupil dilation. BMC Ophthalmol 15(1):1\u20133","journal-title":"BMC Ophthalmol"},{"key":"5730_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2017.04.010","volume":"179","author":"SH Chang","year":"2017","unstructured":"Chang SH, Lee YS, Wu SC et al (2017) Anterior chamber angle and anterior segment structure of eyes in children with early stages of retinopathy of prematurity. Am J Ophthalmol 179:46\u201354","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"5730_CR52","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1167\/iovs.05-0445","volume":"46","author":"EL Smith","year":"2005","unstructured":"Smith EL, Kee CS, Ramamirtham R et al (2005) Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci 46(11):3965\u20133972","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"5730_CR53","first-page":"365","volume":"101","author":"B Mueller","year":"2017","unstructured":"Mueller B, Salchow DJ, Waffenschmidt E et al (2017) Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone. Br J Ophthalmol 101(3):365\u2013370","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"5730_CR54","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","volume":"133","author":"WC Wu","year":"2015","unstructured":"Wu WC, Lien R, Liao PJ et al (2015) Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity. JAMA ophthalmology 133(4):391\u2013397","journal-title":"JAMA ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05730-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:28:12Z","timestamp":1700749692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05730-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5730"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05730-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained in this study even though it is unnecessary for a retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. The study design and protocol followed the guideline of the Helsinki Declaration and were approved by the Institutional Review Board of Taipei Veterans General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}